Evaluation of autoantibodies in oral submucous fibrosis: A clinicopathological study

Evaluation of autoantibodies in oral submucous fibrosis: A clinicopathological study

Background: The autoimmune response may be one of the causative factors for oral submucous fibrosis (OSMF). Serum levels of antinuclear antibodies (ANAs), anti-smooth muscle antibodies (ASMAs), and antithyroid microsomal antibodies (ATMAs) were evaluated in patients with and without OSMF. Objectives...

Full description

Bibliographic Details
Main Authors:	Nallan C S K Chaitanya, Madireddy Nithika, Diksha Chikte, Chelluri Shreya Reddy, R Krathi Kumar, Deepika Vankdoth, Vangapalli Varsha
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Journal of Indian Academy of Oral Medicine and Radiology
Subjects:	antinuclear antibodies indirect immunofluorescence oral submucous fibrosis
Online Access:	http://www.jiaomr.in/article.asp?issn=0972-1363;year=2023;volume=35;issue=3;spage=306;epage=309;aulast=K

Similar Items

Evaluation of the performance of immunoblot and immunodot techniques used to identify autoantibodies in patients with autoimmune diseases
by: EL Hassouni Youssef, et al.
Published: (2021-03-01)

Prevalence of Anti-Dense Fine Speckled 70 Antibodies in Systemic Autoimmune Rheumatic Diseases and Healthy Controls: A Cross-sectional Study
by: MVNL Ram Mohan, et al.
Published: (2023-10-01)

V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells
by: Wilson de Melo Cruvinel, et al.
Published: (2019-07-01)

Detection of Specific Autoantibodies in Sera with Negative Antinuclear Antibody by Indirect Immunofluorescence Assay but Positive by Enzyme Immunoassay
by: Ronnachai Viriyataveekul, et al.
Published: (2019-05-01)

Detection of Specific Autoantibodies in Sera with Negative Antinuclear Antibody by Indirect Immunofluorescence Assay but Positive by Enzyme Immunoassay
by: Ronnachai Viriyataveekul, M.D., et al.
Published: (2019-05-01)

Complex patterns on HEp-2 indirect immunofluorescence assay in a large sample referred for anti-cell autoantibodies detection
by: Wilton Ferreira S. Santos, et al.
Published: (2024-01-01)

A comparative study of efficacy of intralesional corticosteroids and hyaluronidase therapy with and without ultrasound therapy in patients with oral submucous fibrosis
by: Harika Guduru, et al.
Published: (2019-01-01)

Antinuclear antibody-negative systemic lupus erythematosus
by: Krithiga Muralidharan, et al.
Published: (2023-01-01)

Anti-Nuclear antibodies: Current concepts and future direction for diagnosing connective tissue disease
by: K Gautam
Published: (2015-03-01)

The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients
by: Wilton Ferreira Silva Santos, et al.
Published: (2022-08-01)

Standardizing initial dilution titers of antinuclear antibodies for the screening of systemic lupus erythematosus
by: Joseph Sushil Rao, et al.
Published: (2019-01-01)

Autoantibody profile in a cohort of South Indian children with Kawasaki disease
by: Suchetha Rao, et al.
Published: (2014-01-01)

Analysis of Antinuclear Antibody Test Referral Patterns in a Tertiary Care Hospital over Three Years: A Retrospective Observational Study
by: MVNL RamMohan, et al.
Published: (2024-01-01)

Hep-2000 indirect immunofluorescence assay – An emerging screening tool for detection of antinuclear autoantibodies in various connective tissue disorders
by: Arpita Singh, et al.
Published: (2024-12-01)

Polarized microscope assisted study of collagen fibres in Oral Submucous Fibrosis and their clinicopathologic correlation: An in-vitro study
by: Ameena Singh, et al.
Published: (2018-09-01)

The Prevalence and Clinical Relevance of the DFS Immunofluorescence Staining Pattern in a Large ANA-Positive Cohort
by: Chuiwen Deng, et al.
Published: (2022-05-01)

Corrigendum: The prevalence and clinical relevance of the DFS immunofluorescence staining pattern in a large ANA-positive cohort
by: Chuiwen Deng, et al.
Published: (2023-05-01)

Experiência da adoção do I e II Consensos Brasileiros de Fator Antinuclear por Imunofluorescência Indireta em Células HEp-2 em um hospital universitário Experience of an university hospital on the implementation of I and II Brazilian Consensuses for Standardization of ANA in HEp-2 Cells
by: Claudia Cilene Fernandes Correia Laurino, et al.
Published: (2009-04-01)

Oral Submucous Fibrosis- Correlation between Clinical Findings and Histopathological Grading
by: K Prabhu, et al.
Published: (2020-07-01)

Oral Submucous Fibrosis- Correlation between Clinical Findings and Histopathological Grading
by: K. Prabhu, et al.
Published: (2018-08-01)

Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis
by: Packiaraj Selvajothi Ranjitham, et al.
Published: (2023-10-01)

Efficacy of pentoxifylline in the management of oral submucous fibrosis
by: Santosh Patil, et al.
Published: (2014-01-01)

A dermatoglyphic study in oral submucous fibrosis patients
by: Satish Kumar, et al.
Published: (2014-01-01)

Salivary coagulopathy and immunoglobulins in oral submucous fibrosis
by: R Pinakapani, et al.
Published: (2009-01-01)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
by: Thukanaykanpalayam Ragunathan Yoithapprabhunath, et al.
Published: (2013-01-01)

Oral submucous fibrosis and its dermatological relation
by: Fareedi Mukram Ali, et al.
Published: (2014-01-01)

Mast cell mediated myofibroblast differentiation responsible for progression of oral submucous fibrosis
by: Mamatha GS Reddy, et al.
Published: (2024-03-01)

Role of Physiotherapy in HPV Proven Cases of Oral Submucous Fibrosis
by: Farkhanda Syed, et al.
Published: (2023-01-01)

Neutral zone and oral submucous fibrosis
by: Shaista Afroz, et al.
Published: (2012-01-01)

Drug treatment for oral submucous fibrosis: an update
by: Xueru Chen, et al.
Published: (2023-10-01)

Oral Submucous Fibrosis: a case report
by: Mahrokh Imanimoghaddam, et al.
Published: (2019-07-01)

Evaluation of efficacy of turmeric in management of oral submucous fibrosis
by: Nitin Agarwal, et al.
Published: (2014-01-01)

Effectiveness of osteopathic therapy in the treatment of oral submucous fibrosis
by: Manu Goyal, et al.
Published: (2017-01-01)

Downregulation of histone deacetylase 8 (HDAC8) alleviated the progression of oral submucous fibrosis
by: Hui-Wen Yang, et al.
Published: (2023-04-01)

Oral submucous fibrosis: A case report and contemporary review of pathogenesis
by: K B Vinitha, et al.
Published: (2021-01-01)

Matrix metalloproteinase-1 expression in oral submucous fibrosis: An immunohistochemical study
by: Mishra Gauri, et al.
Published: (2010-01-01)

A New Intraoral Appliance for Trismus in Oral Submucous Fibrosis
by: Nallan C. S. K. Chaitanya, et al.
Published: (2018-01-01)

Laparoscopic myomectomy instead of hysteroscopic myomectomy for large submucous fibroids
by: Chin-Jung Wang, et al.
Published: (2013-08-01)

Oral submucous fibrosis in children: Report of three cases and review
by: Tulasi Lakshmi Duggirala, et al.
Published: (2015-01-01)

Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)
by: T. A. Panafidina, et al.
Published: (2023-03-01)